176 related articles for article (PubMed ID: 24494746)
1. Comparison of prednisolone acetate and loteprednol etabonate for the treatment of benzalkonium chloride-induced dry eye syndrome in rats.
Beyazyıldız E; Acar U; Beyazyıldız Ö; Pınarlı FA; Albayrak A; Uğurlu N; Tiryaki M; Delibaşi T
J Ocul Pharmacol Ther; 2014 May; 30(4):306-12. PubMed ID: 24494746
[TBL] [Abstract][Full Text] [Related]
2. A rabbit dry eye model induced by topical medication of a preservative benzalkonium chloride.
Xiong C; Chen D; Liu J; Liu B; Li N; Zhou Y; Liang X; Ma P; Ye C; Ge J; Wang Z
Invest Ophthalmol Vis Sci; 2008 May; 49(5):1850-6. PubMed ID: 18436819
[TBL] [Abstract][Full Text] [Related]
3. Prospective Randomized Trial Comparing Efficacy of Topical Loteprednol Etabonate 0.5% Versus Cyclosporine-A 0.05% for Treatment of Dry Eye Syndrome Following Hematopoietic Stem Cell Transplantation.
Boynton GE; Raoof D; Niziol LM; Hussain M; Mian SI
Cornea; 2015 Jul; 34(7):725-32. PubMed ID: 25850708
[TBL] [Abstract][Full Text] [Related]
4. [Therapeutic effects of Pyranoprofen on the mouse dry eye induced by topical medication of Benzalkonium Chloride].
He H; Liu ZG; Lin ZR; Liu XC; He H; Xiao QG
Zhonghua Yan Ke Za Zhi; 2012 Jan; 48(1):33-40. PubMed ID: 22490914
[TBL] [Abstract][Full Text] [Related]
5. Effect of loteprednol etabonate 0.5% on initiation of dry eye treatment with topical cyclosporine 0.05%.
Sheppard JD; Donnenfeld ED; Holland EJ; Slonim CB; Solomon R; Solomon KD; McDonald MB; Perry HD; Lane SS; Pflugfelder SC; Samudre SS
Eye Contact Lens; 2014 Sep; 40(5):289-96. PubMed ID: 25083776
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic effects of topical doxycycline in a benzalkonium chloride-induced mouse dry eye model.
Zhang Z; Yang WZ; Zhu ZZ; Hu QQ; Chen YF; He H; Chen YX; Liu ZG
Invest Ophthalmol Vis Sci; 2014 May; 55(5):2963-74. PubMed ID: 24722696
[TBL] [Abstract][Full Text] [Related]
7. [Study on the treatment of dry eye with Loteprednol Etabonate].
Wan PX; Wang XR; Song YY; Li ZY; Duan HC; Zhang W; Liu Z; Wang ZC
Zhonghua Yan Ke Za Zhi; 2012 Feb; 48(2):142-7. PubMed ID: 22490950
[TBL] [Abstract][Full Text] [Related]
8. A mouse dry eye model induced by topical administration of benzalkonium chloride.
Lin Z; Liu X; Zhou T; Wang Y; Bai L; He H; Liu Z
Mol Vis; 2011 Jan; 17():257-64. PubMed ID: 21283525
[TBL] [Abstract][Full Text] [Related]
9. Research on the stability of a rabbit dry eye model induced by topical application of the preservative benzalkonium chloride.
Li C; Song Y; Luan S; Wan P; Li N; Tang J; Han Y; Xiong C; Wang Z
PLoS One; 2012; 7(3):e33688. PubMed ID: 22438984
[TBL] [Abstract][Full Text] [Related]
10. Loteprednol etabonate 0.5% versus prednisolone acetate 1.0% for the treatment of inflammation after cataract surgery.
Lane SS; Holland EJ
J Cataract Refract Surg; 2013 Feb; 39(2):168-73. PubMed ID: 23232255
[TBL] [Abstract][Full Text] [Related]
11. Influence of timolol, benzalkonium-preserved timolol, and benzalkonium-preserved brimonidine on oxidative stress biomarkers in the tear film.
Sedlak L; Wojnar W; Zych M; Wyględowska-Promieńska D
Cutan Ocul Toxicol; 2020 Sep; 39(3):260-268. PubMed ID: 32594785
[TBL] [Abstract][Full Text] [Related]
12. Topical loteprednol pretreatment reduces cyclosporine stinging in chronic dry eye disease.
Sheppard JD; Scoper SV; Samudre S
J Ocul Pharmacol Ther; 2011 Feb; 27(1):23-7. PubMed ID: 21133792
[TBL] [Abstract][Full Text] [Related]
13. Protective effects of carbenoxolone, an 11β-HSD1 inhibitor, against chemical induced dry eye syndrome.
Na YJ; Choi KJ; Park SB; Sung HR; Jung WH; Kim HY; Rhee SD; Kim KY
Apoptosis; 2017 Nov; 22(11):1441-1453. PubMed ID: 28887719
[TBL] [Abstract][Full Text] [Related]
14. Comparison of ophthalmic loteprednol etabonate and prednisolone acetate effects on adrenocortical response to ACTH in dogs.
Kline KE; Walton SA; Specht AJ; Santoro D; Watson TJ; Eide ML; Opgenorth TA; Plummer CE
Vet Ophthalmol; 2022 Nov; 25(6):468-475. PubMed ID: 35913421
[TBL] [Abstract][Full Text] [Related]
15. The leaves of Diospyros kaki exert beneficial effects on a benzalkonium chloride-induced murine dry eye model.
Kim KA; Hyun LC; Jung SH; Yang SJ
Mol Vis; 2016; 22():284-93. PubMed ID: 27110091
[TBL] [Abstract][Full Text] [Related]
16. Loteprednol etabonate gel 0.5% vs prednisolone acetate suspension 1% for the treatment of inflammation after cataract surgery in children.
Vittitow JL; Williams JI
J Cataract Refract Surg; 2020 Aug; 46(8):1092-1101. PubMed ID: 32352250
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic Effects of Sodium Hyaluronate on Ocular Surface Damage Induced by Benzalkonium Chloride Preserved Anti-glaucoma Medications.
Liu X; Yu FF; Zhong YM; Guo XX; Mao Z
Chin Med J (Engl); 2015 Sep; 128(18):2444-9. PubMed ID: 26365960
[TBL] [Abstract][Full Text] [Related]
18. Controlled evaluation of loteprednol etabonate and prednisolone acetate in the treatment of acute anterior uveitis. Loteprednol Etabonate US Uveitis Study Group.
Am J Ophthalmol; 1999 May; 127(5):537-44. PubMed ID: 10334346
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the Efficacy of Fluorometholone With and Without Benzalkonium Chloride in Ocular Surface Disease.
Kim YH; Jung JC; Jung SY; Yu S; Lee KW; Park YJ
Cornea; 2016 Feb; 35(2):234-42. PubMed ID: 26619385
[TBL] [Abstract][Full Text] [Related]
20. Loteprednol Etabonate 0.5% Gel Vs. Prednisolone Acetate 1% Solution After Descemet Membrane Endothelial Keratoplasty: Prospective Randomized Trial.
Price MO; Feng MT; Scanameo A; Price FW
Cornea; 2015 Aug; 34(8):853-8. PubMed ID: 26020827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]